Product Information
DASATINIB 100 MG TABLET is a generic product labeled by Biocon Pharma Inc., priced at $26.3180 per EA under NDC 70377008711. Its NADAC has been published 54 times since Jun 18, 2025.
Strength
100 mg/1
Manufacturer
Biocon Pharma Inc.NDC
70377008711
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DASATINIBApproval Type
Generic (ANDA)
FDA Application
ANDA217217On Market Since
3/3/2025
Pharmacological Classes
Price Statistics
The NADAC for DASATINIB 100 MG TABLET has been published 54 times since Jun 18, 2025, and over the history we have for it it has declined 86.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $26.3180 per EA |
|---|---|
| All-time high | $191.7363 (Dec 10, 2025) |
| All-time low | $26.3180 (Jun 17, 2026) |
| 52-week high | $191.7363 |
| 52-week low | $26.3180 |
| Median price | $30.2487 |
| Average price | $107.3104 |
| Largest weekly change | -84.2% (Dec 17, 2025) |
| Weeks tracked | 54 |
| Tracking since | Jun 18, 2025 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DASATINIB 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DASATINIB 100 MG TABLET, manufactured by Biocon Pharma Inc., is $26.3180 per EA (NDC 70377008711), effective Jun 24, 2026.
How has the price of DASATINIB 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for DASATINIB 100 MG TABLET has declined 86.3%. It has been tracked across 54 weekly CMS publications since Jun 18, 2025.
What are the highest and lowest recorded NADAC prices for DASATINIB 100 MG TABLET?
Since Jun 18, 2025, the NADAC for DASATINIB 100 MG TABLET has ranged from a low of $26.3180 (Jun 17, 2026) to a high of $191.7363 (Dec 10, 2025), with a median of $30.2487 per EA.
Are there cheaper alternatives to DASATINIB 100 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as DASATINIB 100 MG TABLET, but none are currently priced below it.
Who manufactures DASATINIB 100 MG TABLET?
DASATINIB 100 MG TABLET (NDC 70377008711) is labeled by Biocon Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification